246 related articles for article (PubMed ID: 2182206)
21. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
22. Acquired von Willebrand's disease in the myeloproliferative syndrome.
Budde U; Schaefer G; Mueller N; Egli H; Dent J; Ruggeri Z; Zimmerman T
Blood; 1984 Nov; 64(5):981-5. PubMed ID: 6333259
[TBL] [Abstract][Full Text] [Related]
23. von Willebrand's disease.
Perry JJ; Alving BM
Am Fam Physician; 1990 Jan; 41(1):219-24. PubMed ID: 2403725
[TBL] [Abstract][Full Text] [Related]
24. Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with von Willebrand's disease.
Garicochea B; D'Amico EA; Bydlowski SP; Chamone DA
Ann Hematol; 1991; 62(2-3):81-2. PubMed ID: 1903313
[No Abstract] [Full Text] [Related]
25. Use of desmopressin in a patient with von Willebrand's disease undergoing podiatric surgery.
Felts TJ; Scurran BL; Karlin JM
J Am Podiatr Med Assoc; 1995 Jun; 85(6):325-7. PubMed ID: 7602506
[TBL] [Abstract][Full Text] [Related]
26. [Patients with moderate von Willebrand's disease. Response to Willebrand factor with DDAVP].
Alphonse O
Soins; 1989; (526-527):3-4. PubMed ID: 2814607
[No Abstract] [Full Text] [Related]
27. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L; Boggio L; Green D
Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
[No Abstract] [Full Text] [Related]
28. Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.
Isola L; Forster A; Aledort LM
Ann Intern Med; 1984 Nov; 101(5):719-20. PubMed ID: 6435493
[No Abstract] [Full Text] [Related]
29. Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patients.
Mariana G; Ciavarella N; Mazzucconi MG; Antoncecchi S; Solinas S; Ranieri P; Pettini P; Agrestini F; Mandelli F
Clin Lab Haematol; 1984; 6(3):229-38. PubMed ID: 6440729
[TBL] [Abstract][Full Text] [Related]
30. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
[TBL] [Abstract][Full Text] [Related]
31. The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's Organization.
Lethagen S; Flordal P; Van Aken H; Hunt BJ; Cattaneo M
Eur J Anaesthesiol Suppl; 1997 Mar; 14():19-22. PubMed ID: 9088830
[TBL] [Abstract][Full Text] [Related]
32. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
Theiss W; Schmidt G
Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
[No Abstract] [Full Text] [Related]
33. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
[No Abstract] [Full Text] [Related]
34. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
[TBL] [Abstract][Full Text] [Related]
35. [Desmopressin in hemophilia A and Von Willebrand's disease].
Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
[TBL] [Abstract][Full Text] [Related]
36. Transfusion medicine management for reconstructive spinal repair in a patient with von Willebrand's disease and a history of heavy surgical bleeding.
Bolan CD; Rick ME; Polly DW
Spine (Phila Pa 1976); 2001 Dec; 26(23):E552-6. PubMed ID: 11725256
[TBL] [Abstract][Full Text] [Related]
37. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
[No Abstract] [Full Text] [Related]
38. Clinical evaluation of subcutaneously administered DDAVP.
Ghirardini A; Chistolini A; Tirindelli MC; Di Paolantonio T; Iacopino G; Mariani P; Chirletti P; Agrestini F; Mariani G
Thromb Res; 1988 Feb; 49(3):363-72. PubMed ID: 3259021
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of the chromogenic assay of factor VIII in haemophilia A, and different variants of von Willebrand's disease.
Lethagen S; Ostergaard H; Nilsson IM
Scand J Haematol; 1986 Nov; 37(5):448-53. PubMed ID: 3101169
[TBL] [Abstract][Full Text] [Related]
40. [Variant forms of von Willebrand's disease].
Papaian LP; Golovina OG
Ter Arkh; 1990; 62(7):86-92. PubMed ID: 2251672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
